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doi:10.1016/j.jfma.2011.01.003Background/Purpose: This study examined the effects of a 5-HT1A receptor agonist
(8-OH-DPAT) on external urethral sphincter (EUS) activity in urethane-anesthetized rats.
Methods: An EUS electromyogram (EMG) and intravesical pressure (IVP) were simultaneously
recorded during continuous cystometrographic monitoring, to provide a quantitative evalua-
tion of EUS activity and urethral urodynamics of voiding.
Results: When examining the EUS burst activity, durations of the active (AP) and silent periods
(SP) as a function of the time axis, respectively, exhibited concave- and convex-shaped curves.
The burst discharges of the EUS-EMG were divided into nonvoiding and voiding burst activities
based on the oscillation waves of the IVP, which were located in Phases 1 and 2 of the IVP. After
8-OH-DPAT treatment, the entire burst period in Phases 1 to 2 of the IVP was significantly pro-
longed. The average SP in both Phases 1 and 2 significantly increased but the average APs were
not affected. Urodynamic results showed decreases in the volume threshold, contraction
amplitude, and residual volume as well as an increase in the contraction duration. In addition,
the amplitude of bladder high-frequency oscillatory waves in the IVP and the average urethral
flow rate were reduced, but the entire voiding efficiency increased.
Conclusion: The influences of 8-OH-DPAT on EUS burst activity and urodynamics were exactly
detected by the sophisticated EMG analytic design, and the results could be a reference for the
pharmacological treatment of patients with lower urinary tract dysfunction.
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68 S.-C. Chen et al.Introduction Materials and methodsStress urinary incontinence (SUI) is one of the most common
forms of incontinence among middle-aged women.1 Sero-
tonergic agents (e.g., Duloxetine) are used to treat SUI
in patients.2 However, recent studies continue to inves-
tigate the effects of serotonergic ligands on the bladder
activity in animals. Serotonin (5-hydroxytryptamine,
5-HT) was characterized into 14 structurally different
5-HT receptors in mammalian species, which are divided
into seven subfamilies (5-HT1 to 5-HT7).
3 Studies indi-
cated that some 5-HT receptors, i.e., 5-HT1, 5-HT2, and
5-HT3 receptors, are involved in the control of lower
urinary tract (LUT) function. These 5-HT receptors and
terminals are located on spinal cord areas that contain
afferent and efferent components of LUT neural control
centers.4 These receptors seem to modulate all of the
pathways involved in the control of micturition, including
the parasympathetic, sympathetic, and somatic
pathways.5
The 5-HT1A receptor is one of the most extensively
investigated agents and has been used in various animal
pharmacological experiments including the rat, guinea pig,
and cat.3 However, contradictory results spurred various
interpretations of the function of this receptor subtype in
different animal species. A great deal of our original
understanding of 5-HT mechanisms involved in controlling
micturition came from cat experiments. For example,
8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) signif-
icantly increased both the bladder volume threshold and
the intercontraction interval, and thus moderately inhibi-
ted bladder activity in cat experiments.6,7 However, the
bladder-inhibition effect is exactly the opposite of the
bladder-excitatory effects of 8-OH-DPAT reported in rats.8,9
As the rat model has now become the main species for
investigating urine storage and micturition reflexes, it is
essential to precisely define the regulatory functions of
5-HT1A receptors in the LUT of rats.
Although recent studies continue to investigate the
effects of 5-HT ligands on bladder activity, most rat studies
focus on measuring urodynamic parameters, to detect the
volume threshold (VT), changes in the VT, bladder pressure,
voided volume (VV), and residual volume (RV).10e12 As
external urethral sphincter (EUS) burst activity plays an
important role in the micturition reflex in the rat,13 the
electrophysiological effects of 5-HT on EUS activity require
further investigation. In our recent studies, we developed
a novel experimental design to analyze EUS burst
discharges in urethane-anesthetized rats after nerve
damage.14 In the present study, we continue exploiting this
method to examine the role of the 5-HT1A receptor in
controlling the micturition reflex by activating 5-HT1A
receptors with 8-OH-DPAT (a 5HT receptor agonist) in
urethane-anesthetized female rats. In addition, a new
experimental design was used to analyze patterns of the
external urethral sphincter electromyographic (EUS-EMG)
burst discharges in time domain. Both EUS-EMG and intra-
vesical pressure (IVP) were measured during continuous
cystometrography (CMG) to provide a quantitative evalua-
tion of interactions between EUS activity and urodynamics
during micturition.General preparation
A total of 21 female SpragueeDawley rats (weighing
290e360 g) were used in this study. All rats were anesthetized
with urethane (1.2 g/kg, s.c.). Body temperature was main-
tained at 36e38C by a heating lamp. In addition, the femoral
vein was catheterized for fluid and drug administration. The
entire procedure was approved by the Institutional Animal
Care and Use Committee of Taipei Medical University.
The urinary bladder was exposed via a midline abdom-
inal incision. Two insulated silver wire electrodes (0.05 mm
in diameter) with exposed tips were inserted into the
lateral sides of the mid-urethra, where the muscle fibers of
the EUS were identified. The recorded EUS-EMG was similar
to that recorded from electrodes implanted into the
exposed EUS via a pubic symphysis incision and was also
completely blocked after neuromuscular blockade with
pancuronium bromide (1.0e1.5 mg/kg i.v., pancuronium,
Organon, Istanbul, Turkey), which confirmed that the EMG
activity originated in striated sphincter muscles. A poly-
ethylene (PE) tube 60 (1.0 mm ID and 1.5 mm OD) was then
inserted into the bladder lumen for bladder pressure
measurements. The bladder end of the PE tube was heated
to form a collar and then passed through a small incision at
the apex of the bladder dome. After the collar of the tube
was tightened, the abdominal wall was closed with nylon
sutures. The PE tube was in turn connected via a three-way
stopcock to an infusion pump for filling with physiological
saline and to a pressure transducer to monitor bladder
pressure. The rats underwent urodynamic and EUS-EMG
examinations that usually began 3e4 hours after the
induction of anesthesia. The bladder pressure and EUS-EMG
were first amplified and sampled at 12-bit resolution using
a biological signal acquisition system (Biopac MP 150,
BIOPAC Systems, Santa Barbara, CA, USA).Physiological investigations
In the experiments, 8-OH-DAPT (0.3 mg/kg dissolved in
saline, Sigma, St. Louis, MO, USA) was administered by an
intravenous injection based on previous studies.9,15
Different doses of 8-OH-DPAT injected into the same
animal were at approximately 40e60-minute intervals from
each other. All rats underwent urodynamic and EUS-EMG
examinations after the vehicle or drug dosing. The first
post-treatment urodynamic and EUS-EMG examinations
were usually completed within 30e45 minutes after drug
administration. Transvesical cystometry was performed at
an infusion rate of 0.123 mL/minute with physiological
saline at room temperature.16 The urethra was opened to
allow elimination of fluid during micturition. The infusion
pump was turned off after three voiding contractions.
Various cystometric parameters were measured: (i) the
micturition VT, which is the volume of saline sufficient to
induce the first voiding contraction; (ii) contraction
amplitude (CA), which is the maximal pressure during
voiding; and (iii) bladder contraction duration (CD) during
voiding, as shown in Fig. 1A. Additional urodynamic
Figure 1 Typical pattern of intravesical pressure (IVP) (upper traces) and external urethral sphincter electromyography
(EUS-EMG) recorded during a continuous transvesical infusion cystometrographic (CMG) measurement in the anesthetized rat.
(A) Bladder micturition contractions were measured with a constant rate (0.123 mL/minute) of the intravesical saline infusion,
which was accompanied by large-amplitude EUS-EMG activity. The CMG parameters include micturition volume threshold (VT),
contraction duration (CD), intercontraction interval (ICI), and contraction amplitude (CA). (B), (C), (D), and (E) are expansions in
the time scale of the recording in (A). The parentheses indicate the recording periods in (B), (C), (D), and (E), respectively, at faster
time scales. A micturition contraction was divided into the three phases of bladder activity in (B). The burst period (BP) in the
EUS-EMG can be clearly observed in (C), which lasted from the end of Phase 1 throughout the entire duration of Phase 2. The BP in
(D) could be divided into nonvoiding and voiding burst activities, which were located in Phases 1 and 2, respectively. The voiding
burst activity was accompanied by the IVP superimposed with a series of high-frequency oscillations (HFOs) but the nonvoiding
bursts did not cause any oscillation waves in the IVP. (E) Individual bursts were composed of active (APs) and silent periods (SPs).
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Effect of 8-OH-DPAT on EUS activity 71parameters were obtained: RV, VV, and voiding efficiency
(VE). RV is the volume of saline withdrawn through the
intravesical catheter after micturition. The collection of
fluid was facilitated by manually pressing on the abdominal
wall. VV is represented as the VT minus the RV, and the
ratio between VV and VT is computed as VE. The person
conducting the EMG activity analysis was blinded to the
status of the rat. As described in earlier papers,17 a single
micturition contraction of the bladder can be divided into
three phases of IVP (Fig. 1). Various EUS-EMG parameters in
Phases 1 and 2 of IVP were measured including the average
duration of the burst period (BP), the silent period (SP), the
active period (AP), the number of SPs (Num), the frequency
of the burst discharge (FB), and the average urethral flow
rate (the ratio of the VV to the BP, VV/TSP). All data ob-
tained from three micturition contractions were averaged
for each animal with the aid of Acqknowledge software
(BIOPAC Systems).
Statistical analysis
All parameters obtained from CMGs and EUS-EMG are pre-
sented as the mean value standard deviation (SD). The
parameters obtained after vehicle and drug administration
were statistically compared using the Student t-test. A p
value <0.05 was considered statistically significant.
Results
Typical pattern of bladder activity and EUS-EMG
during CMG
Typical IVP and EUS-EMG measurements are depicted in
Fig. 1A. The rat after vehicle treatment exhibited mictu-
rition contractions during the continuous intravesical infu-
sion of saline. EUS-EMG exhibited low-amplitude tonic
activity during the initial filling phase of CMG or between
micturition contractions but it markedly increased in
amplitude during bladder contractions. According to Maggi
et al, 17a single micturition contraction of the bladder can
be divided into three phases of IVP: Phase 1, rising phase;
Phase 2, high-frequency oscillation (HFO) phase; and Phase
3, rebound and falling phase, as shown in Fig. 1B. During
a single micturition contraction, the EUS-EMG clearly shows
a long BP, which lasted from the end of Phase 1 throughout
the entire duration of Phase 2, as depicted in Fig. 1C. In
most cases (nZ 18 of 21 rats), the BP could be divided into
nonvoiding and voiding burst activities, which was charac-
terized by HFO waves in the IVP (Fig. 1D). The nonvoiding
burst activity at Phase 1 usually appeared for a short period
(for < 1 second) and was not accompanied by anyFigure 2 Comparison of the intravesical pressure (IVP) (top traces
activity (bottom traces) of the three phases of micturition after
anesthetized rat. Typical patterns of micturition contraction record
(A) and (B), respectively. The parentheses in (A) indicate the rec
Similarly, (D) and (F) are expansions of plots in (B) marked with pare
DPAT treatment, the duration of nonvoiding burst activity was elon
activity was elongated in Phase 2 (shown in A and B). In Phase 3, t
(compare E and F).oscillation waves in the IVP. However, the voiding burst
activity at Phase 2 usually lasted 3e5 s and was accompa-
nied by the IVP superimposed with a series of HFOs. Burst
discharges in the BP were characterized by clusters of high-
frequency spikes (AP) separated by periods of quiescence
(SP), as shown in Fig. 1E.
The effect of 8-OH-DPAT on the three phases of
micturition contractions
Similar to the control CMG, the rat after 8-OH-DPAT treat-
ment still exhibited regular voiding contractions during the
recordings. Typical patterns of the IVP and EUS-EMG
activity during the three phases of micturition recorded
from the same rat after vehicle and drug treatments are
compared in Fig. 2A and 2B, respectively.
After vehicle treatment, EUS-EMG gradually increased
its tonic discharge during Phase 1, in parallel with the
sharply increased IVP (Fig. 2A,C). At approximately the end
of Phase 1, EUS-EMG with a short period of a nonvoiding
burst discharge (approximately 1 second) was recorded, as
depicted in Fig. 2C. During this period, no apparent urina-
tion was found as the bladder neck or proximal urethral
sphincter was still closed (no HFOs in the IVP). During Phase
2, a series of HFOs was superimposed on the IVP. The HFOs
were correlated with the voiding burst discharge of EUS-
EMG. Meanwhile, HFOs were commonly accompanied by
the emission of fluid in a stream-like manner. During Phase
3, the IVP initially appeared as a rebound pressure, fol-
lowed by a rapid fall in the IVP (Fig. 2E). The EUS-EMG
converted to tonic-type activity during Phase 3. No urine
was expelled during this phase.
After 8-OH-DPAT treatment, the pattern of micturition
contractions prominently altered the IVP of all three pha-
ses. In Phase 1, the IVP slowly increased (compared to that
in Fig. 2C) with a prolonged duration of the rising phase, as
shown in Fig. 2D. As a result, the maximal amplitude of the
IVP was dramatically reduced compared to the controls.
In addition, during this phase, almost the entire tonic
EUS-EMG was transformed into nonvoiding burst activity
(approximately 3e5 s) until the end of Phase 1, as shown in
Fig. 1D. This phenomenon should not have been due to an
overdose of the drug, as it can be produced in anesthetized
rats even at low doses of 8-OH-DPAT. During Phase 2, the
entire period of the burst discharge was significantly pro-
longed, which is in parallel with the occurrence of HFOs in
IVP (Fig. 2B,D). Observations at the urethral outlet showed
that urine was emitted in a long stream-like pattern during
this phase. By contrast, the amplitude of HFO waves in the
IVP during this phase was significantly reduced compared to
the controls, as shown in Fig. 3. In Phase 3, the voiding
burst activity of EUS-EMG was transformed into a tonic) and external urethral sphincter electromyographic (EUS-EMG)
administration of vehicle and 0.3 mg/kg of 8-OH-DPAT to an
ed from one rat after vehicle and drug treatments are shown in
ording period micturition in (C) and (E) at faster time scales.
ntheses. Comparing the phase durations before and after 8-OH-
gated in Phase 1 (compare C with D), and the duration of burst
he rebound pressure of the IVP almost completely disappeared
Figure 3 Comparison of the amplitude of bladder high-frequency oscillatory (HFO) waves (in Phase 2) after vehicle and 8-OH-
DPAT (0.3 mg/kg) treatments. (A) After vehicle administration, a HFO wave was in parallel with external urethral sphincter
electromyographic (EUS-EMG) burst discharges. (B) The amplitude of bladder HFO waves was reduced by 8-OH-DPAT treatment.
Note that the duration of the silent period (SP) was significantly increased while the numbers of burst discharges were less than
those after vehicle treatment.
72 S.-C. Chen et al.discharge, and gradually decreased (Fig. 2F). Similar to
Phase 1 of the IVP, bladder contractions showed a pro-
longed and slowly descending IVP. But the rebound pressure
detected in control rats had almost disappeared or was
unclear after drug administration.
The pattern of burst activity
The 5-HT receptor agonist (8-OH-DPAT) induced a long BP
lasting from Phases 1 to 2 (Fig. 2B). When examining the
distribution of the duration of the burst discharges in
detail, the burst discharges were transformed into two
curves: SP and AP curves. The curves are the function of the
durations of the AP and SP to the corresponding time axis
which was represented as the middle of the duration of
each AP or SP, as shown in Fig. 4A. Typical patterns of SP
and AP curves after vehicle and 8-OH-DPAT treatments are,
respectively, shown in Fig. 4B and 4C. In most cases (nZ 17
of 21 rats), vehicle treatment, the AP curve exhibited
a concave-like shape whereas the SP curve showed
a convex shape (Fig. 4B). During the nonvoiding burst
activity in Phase 1, the AP and SP curves showed an
asymptotic decrease (starting from 100 ms) and increase
(starting from 60 ms), respectively, until the end of Phase
1. At the beginning of Phase 2 or the middle of Phase 2, the
AP and SP curves almost reached the bottom around 60
milliseconds and a plateau around 100 milliseconds,
respectively. Finally, the AP curve at the end of Phase 2
asymptotically ascended to around 80 milliseconds,
whereas the SP curve asymptotically descended close to
the initial value of the curve.
After 8-OH-DPAT (0.3 mg/kg) treatment, the entire AP
and SP curves were both elongated approximately 2.5-fold
that of the control (Fig. 4C). The initial value of the
AP curve was elevated to 150 milliseconds, and then the AP
curve exhibited an asymptotic decrease to the end of Phase
1 and reached the bottom around 60 milliseconds to the
end of Phase 2. In contrast to the control AP curve, AP after
treatment did not show an ascending phase at the end of
Phase 2. The SP curve showed a sharply increasing curvewhich soon formed a plateau at the beginning of the curve.
The plateau was elevated up to around 150 milliseconds
and lasted from Phase 1 to the end of Phase 2. During the
plateau period, there were several sporadic SPs with very
long durations which reached 300 milliseconds in some
cases.Measurements of EUS-EMG and bladder activity
parameters
The drug effects on the relationship between bladder
activity and EUS-EMG parameters were determined during
continuous CMGs in rats. The summary of changes in the
urodynamic and EUS-EMG parameters in rats (nZ 12) after
intravenous administration of vehicle and 8-OH-DPAT is
tabulated in Tables 1 and 2, respectively.
During the CMGs, the average VT for stimulating voiding
significantly decreased after 5-HT treatment compared to
that of the vehicle (Table 1). Moreover, the average
maximal CA during voiding was significantly reduced after
5-HT treatment. 8-OH-DPAT slightly reduced the average VV
from 0.44 to 0.39 mL, but there was no significant differ-
ence compared to the vehicle. In addition, the CD signifi-
cantly increased after administering the 5-HT receptor
agonist (23.94 2.40 vs. 31.92 7.63 seconds, p < 0.05).
The RV significantly decreased in rats with 5-HT treatment
(0.05 0.02 mL) compared to values (0.19 0.03 mL) in
vehicle. The average VE, i.e., the ratio of VV to VT, in
rats after 5-HT treatment had markedly increased from
approximately 68% to 88%.
By contrast, EUS-EMG measurements in rats with vehicle
treatment, the average duration of the BP in Phase 1
(0.86 0.47 seconds) was much shorter than that in Phase 2
(3.91 0.50 seconds) (Table 2). In addition, the SP in Phase
1 (69.1 5.4 milliseconds) was much shorter than that in
Phase 2 (98.5 3.4 milliseconds), but the AP in Phase 1
(99.4 3.8 milliseconds) was much longer (65.6 2.9
milliseconds) than that in Phase 2. After 8-OH-DPAT treat-
ment, the average durations of the BP in Phases 1 and 2 had
Figure 4 Comparison of the durations of the active (AP) and
silent periods (SP) in the time domain after vehicle and 0.3 mg/
kg of 8-OH-DPAT treatments. (A) A typical example of the burst
discharges of external urethral sphincter electromyography
(EUS-EMG) transformed into the function of the duration of the
AP or SP to its corresponding time domain. The x-axis values
are the middle of the duration of each AP or SP, marked with
downward arrows. In the rat after vehicle treatment, the AP
Effect of 8-OH-DPAT on EUS activity 73significantly increased by approximately 4- and 2-fold of
the vehicle, respectively. Moreover, the average durations
of the SP were significantly increased in Phase 1 (by
approximately 1.8-fold that of the vehicle) and in Phase 2
(by approximately 1.7-fold that of the control), but no
significant difference was found in the average durations of
the AP in Phases 1 or 2 compared to the vehicle. In addition,
the average frequency of bursting discharge (FB) and the
ratio of the Num to the BP significantly decreased in both
Phases 1 (from 5.95 to 4.48 Hz) and 2 (from 6.05 to
4.19 Hz). The averaged urethral flow rate (VV/TSP) in Phase
2 was significantly reduced by 8-OH-DPAT.
Discussion
The present results indicate that activation of 5-HT1A
receptors by 8-OH-DPAT significantly affected the pattern
of EUS-EMG burst activity and urodynamic parameters in
female urethane-anesthetized rats. In control EUS-EMG,
we detected a short period of burst discharges before
the oscillation waves of IVP, called the nonvoiding burst
activity. After drug administration (0.3 mg/kg, i.v.), the
entire tonic EUS-EMG in Phase 1 of the IVP was almost
completely transformed into nonvoiding burst activity in
which the duration of the SP increased. EMG activity
occurring during bladder filling would originate from stri-
ated muscles rather than smooth muscles as noted in our
previous studies, because EMG activity was eliminated after
acute nerve transection or administration of a neuromus-
cular blockade agent.14 Other studies showed that 8-OH-
DPAT acts on at least two different and independent sites of
the central nerve system (CNS): one at the spinal cord and
the other at the supraspinal level.15 Recent studies indi-
cated that burst activity was detected in rats with acute
and chronic spinal cord injuries after giving 8-OH-DPAT via
i.v. administration.18 Therefore, the possible action site for
initiating nonvoiding burst activity is located at the spinal
cord level, but determining the involved segments of the
spinal cord requires further experiments. In general, our
results show that 8-OH-DPAT might have an excitatory
effect on somatic pathways in the spinal cord and may
trigger the generator of EUS burst activity early during
voiding.
We examined the pattern of burst activity by observing
the SP curve as a function of its time course. In control
data, the SP curve exhibited a convex-like shape during the
BP. It asymptotically increased at the beginning of the BP
and decreased at the end of the BP. Interestingly, this
pattern is similar to that indicated by previous studies of
the urethral flow rate of female rats gradually increasing
at the beginning and declining at the end of the voidingcurve exhibited a concave-like shape, whereas the SP curve
showed a convex curve in (B). At the end of Phase 1, the AP and
SP curves asymptotically reached the bottom and plateau, and
then at the end of Phase 2 the curves gradually increased and
decreased, respectively. (C) After the administration of 8-OH-
DPAT, both the AP and SP curves were prominently elongated.
The AP and SP curves reached the bottom and plateau prior to
the end of Phase 1, and then remained at the bottom and
plateau until the end of Phase 2, respectively.
Table 1 Parameters of bladder activity after administration of vehicle and 8-OH-DPAT in the rat.
(nZ 12) VT
(mL)
CA
(cm H2O)
CD
(s)
VV
(mL)
RV
(mL)
VE
(%)
Vehicle 0.64 (0.10) 24.98 (1.22) 23.94 (2.40) 0.44 (0.12) 0.19 (0.03) 68.17 (9.4)
8-OH-DPAT (0.3 mg/kg) 0.44* (0.10) 20.24* (1.96) 31.92* (7.63) 0.39 (0.08) 0.05* (0.02) 88.39* (3.94)
Values are Mean SD.
*A p-value <0.05 indicates a statistically significant difference compared with vehicle treatment.
CAZ contraction amplitude; CDZ contraction duration; RVZ residual volume; VEZ voiding efficiency: VV/VT; VTZ volume threshold;
VVZ voided volume.
74 S.-C. Chen et al.period.19 Therefore, the duration of the SP rather than the
AP is an important factor influencing bladder emptying.
By contrast, the asymptotical increase at the beginning
of the BP (approximately 1 second in most rats) is located
in Phase 1, which is prior to the appearance of bladder
high-frequency oscillation waves in the IVP. We think this
phenomenon might be due to the EUS burst activity
appearing before bladder neck opening. Therefore, it
cannot detect any fluid drops around the urethral outlet
during this period or oscillation waves in the IVP. Hence,
the nonvoiding burst activity was markedly prolonged by up
to approximately 3.6 s after 8-OH-DPAT treatment. The
entire tonic EUS-EMG activity for the entire Phase 1 was
transformed into burst discharges. However, the actual role
of nonvoiding burst activity requires further explanation.
Previous studies indicated that the EUS acts as a valve
which permits fluid to escape from the bladder and accel-
erates the flow that generates the fast flow rate peaks.20
These nonvoiding bursts might act as a warm-up period
for EUS activity to make micturition more efficient in
Phase 2.
In our results, the general effect of 8-OH-DPAT enhanced
the VE in anesthetized female rats. This could be accoun-
ted for by several mechanisms. First, the burst activity of
EUS-EMG in Phase 2 reflects the rhythmic opening and
closing of the outlet to produce the pulsatile flow of urine
that is common in rodents. Electrophysiological studies
showed that the EUS-EMG in normal control rats exhibits
a 4e8-Hz BP during voiding.17 The EUS-EMG bursting,
particularly occurring during the SP, represents the relax-
ation and opening of the outlet which is essential to achieve
efficient voiding.16 Our previous study showed that rats
with pudendal nerve injury exhibited a decreased duration
of the SP as well as an increased frequency of EUS-EMG
bursting, and thus a decreased duration of urethral
opening which caused voiding inefficacy.14 On the contrary,
our current results indicated that 8-OH-DPAT increased the
duration of the SP of EUS-EMG bursting. Thus, the urethra
was open for a longer period permitting urine evacuation
from the urethra which may have partially contributed to
the increased voiding efficiency.
Another possibility is that 8-OH-DPAT might alter bladder
activity (decreased VT but increased CD) during the CMG
measurements. Our results indicated that 8-OH-DPAT
decreased the VT but did not significantly decrease the
value of the VV. In addition, 8-OH-DPAT increased the
bladder CD supporting the fact that the drug enhances
bladder contractile ability to maintain the same level of VV
as in the controls. Above all, results indicated that8-OH-DPAT could enhance bladder evacuation by decreasing
the VT and improving bladder contractions. It is also note-
worthy that 8-OH-DPAT increased the duration of both the
SP and CD. Studies reported that stimulation of urine flow
to the urethra could excite afferent nerves and in turn
facilitate reflex bladder contractions.21 This facilitative
urethra-to-bladder reflex could promote complete bladder
emptying. This assumption was supported by our present
results. The increase in the duration of the SP represented
an increased duration of urine flow stimulation to the
urethra. Thus, the urethra-to-bladder reflex was enhanced
and sustained for a longer duration of bladder emptying.
By contrast, 8-OH-DPAT decreased the bladder CA during
CMG. This result seems to be inconsistent with the
consensus that 8-OH-DPAT enhances bladder CA and thus
improves VE. This might be attributed to 8-OH-DPAT
affecting EUS-EMG activity during the burst period (by
increasing the SP). The increase in the duration of the SP in
Phase 2 of the BP indicated that the rat had longer relax-
ation and opening durations in the urethral outlet as well as
lower urethral outlet resistance during bladder evacuation.
This assumption, supported by recent studies, indicated
that 8-OH-DPAT increased bladder CA during transurethral
CMG with the ligation of bladder outlet.9 Therefore, 8-OH-
DPAT markedly decreased the amplitude of the bladder
contraction that occurred with longer SPs.
In contrast to the amplitude of bladder contractions, the
amplitude of HFO waves in the IVP during burst activity was
significantly reduced by 8-OH-DPAT (Fig. 3). Intuitively, this
implies that 8-OH-DPAT reduced the pulsatile effect, which
is adverse for efficient urine expulsion during voiding.
Surprisingly, 8-OH-DPAT treatment did not reduce the
bladder’s voiding function but produced a positive effect
on VE. This might be attributed to improved bladder
contractions and lengthened urethral opening periods
induced by the drug to compensate for the lower urethral
flow rate. However, further experiments are needed to
quantify the roles of detrusor contractions and EUS burst
activity in VE.
In this study, the average urethral flow calculated by the
ratio of void volume to burst period (VV/TSP) might not
exactly reflect the real flow velocity, because the real
urethral flow in the rat should be a nonlinear trans-
formation pattern due to the intermittent EUS activity.
However, the experimental design could be useful to
determine the relationship between urodynamics and EUS-
EMG. The urethral flow rate was reduced by 8-OH-DPAT,
which is reasonable as the drug simultaneously lengthened
the urethral opening periods (silent period, see Table 2).
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Effect of 8-OH-DPAT on EUS activity 75In summary, the present results indicate that the typical
pattern of EUS-EMG burst activity in urethane-anesthetized
rat exhibited a concave and a convex waveform in AP and
SP curves, respectively. The burst activity was markedly
prolonged by the activation of 5-HT1A receptor with 8-OH-
DPAT treatment. Moreover, the drug also altered voiding
efficiency due to a longer excitation of bladder activity
coinciding with prolonged urethral opening periods during
micturition. These results provide a more detailed under-
standing of the properties of the relationship between
urodynamics and EUS-EMG after 8-OH-DPAT treatment that
could promote the development of pharmacological-based
treatments for lower urinary tract dysfunction.Acknowledgments
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